Literature DB >> 17523772

Quality of life in sexually active men with symptomatic benign prostatic hyperplasia : effects of treatment.

Mel P Daly1.   

Abstract

Quality of life (QOL), sexuality in particular, has become an important consideration in treatment decisions for men with lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH). To determine the impact of these conditions on sexual function and QOL in older men, this article provides a review of clinical data on the relationship between sexual dysfunction and symptom severity, effective clinical assessment, treatment options, and the influence of current therapies on sexual function and QOL. The various symptoms of BPH can adversely affect sexual functioning and therefore QOL. Moreover, there may be a direct association between symptom severity and sexual dysfunction that may affect QOL.Patients base their decisions regarding treatment choices for BPH more on anticipated relief of lower urinary tract symptoms and improved QOL (including sexual functioning) than on improvements in physical measures. Although medications and surgery may relieve LUTS, sexual dysfunction is a common adverse result. Newer pharmacological interventions such as specific alpha-adrenergic blocking agents like tamsulosin may help improve sexual function and QOL in men with symptomatic BPH.

Entities:  

Year:  2005        PMID: 17523772     DOI: 10.2165/00044011-200525040-00001

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  54 in total

Review 1.  Phytotherapy in the management of benign prostatic hyperplasia.

Authors:  F C Lowe
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

2.  Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men.

Authors:  R O Roberts; M M Lieber; T Rhodes; C J Girman; D G Bostwick; S J Jacobsen
Journal:  Urology       Date:  1998-04       Impact factor: 2.649

3.  One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General Practice.

Authors:  B Lukacs; J C Grange; D Comet
Journal:  Urology       Date:  2000-04       Impact factor: 2.649

4.  Quality of life and sexual function in patients with benign prostatic hyperplasia.

Authors:  Reginald C Bruskewitz
Journal:  Rev Urol       Date:  2003

5.  Sexual function in 131 patients with benign prostatic hyperplasia before prostatectomy.

Authors:  J Baniel; S Israilov; J Shmueli; E Segenreich; P M Livne
Journal:  Eur Urol       Date:  2000-07       Impact factor: 20.096

Review 6.  Benign prostatic hyperplasia: natural evolution versus medical treatment.

Authors:  F C Da Silva
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

Review 7.  Sexual dysfunction in patients with benign prostatic hyperplasia.

Authors:  T M Downs; M P O'Leary
Journal:  Curr Opin Urol       Date:  1999-01       Impact factor: 2.309

8.  Three-year prospective study of 3228 clinical BPH patients treated with alfuzosin in General Practice.

Authors:  B Lukacs; J C Grange; D Comet; C McCarthy
Journal:  Prostate Cancer Prostatic Dis       Date:  1998-09       Impact factor: 5.554

Review 9.  Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia.

Authors:  Gerald L Andriole; Roger Kirby
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

10.  Transurethral resection versus incision of the prostate: a randomized, prospective study.

Authors:  M Riehmann; J M Knes; D Heisey; P O Madsen; R C Bruskewitz
Journal:  Urology       Date:  1995-05       Impact factor: 2.649

View more
  2 in total

Review 1.  Integrative medicine: complementary therapies and supplements.

Authors:  Barrie R Cassileth; Jyothirmai Gubili; K Simon Yeung
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

2.  Statins and male sexual health: a retrospective cohort analysis.

Authors:  Richard Davis; Kelly R Reveles; Sayed K Ali; Eric M Mortensen; Christopher R Frei; Ishak Mansi
Journal:  J Sex Med       Date:  2014-11-25       Impact factor: 3.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.